Skip to content

MPL PHARMA: what changed

BE 0885.177.557NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2025 and 2026

Net result for the year
€111,202
2025 · €113,425-€2,223
Equity
€724,397
2025 · €724,196+€202
Cash
€336,008
2025 · €232,594+€103,414
Balance sheet total
€1.1m
2025 · €1.2m-€131,209

Largest movements

2025 to 2026
Assets
  • Current investments -€150,000

    no longer reported in 2026; in 2025 it stood at €150,000

  • Cash +€103,414

    up €103,414 (+44.5%), from €232,594 to €336,008

    mainly Current investments (+€150,000) and Net result for the year (+€111,202)

  • Tangible fixed assets -€59,298

    down €59,298 (-11.0%), from €539,794 to €480,496

    of which Land and buildings: -€47,330

  • Intangible fixed assets -€22,189

    down €22,189 (-21.1%), from €105,399 to €83,209

Equity and liabilities
  • Other debts -€88,686

    down €88,686 (-45.9%), from €193,091 to €104,405

  • Debts after one year -€46,480

    down €46,480 (-54.3%), from €85,531 to €39,051

Income statement

No income-statement line moved by more than 1% of the activity.

    Change in the result, 2025 to 2026

    effect on the result

    For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

    Result 2025 €113,425
    Gross operating margin -€1,631
    Staff costs +€3,097
    Depreciation +€391
    Other operating charges -€158
    Other operating items -€3,570
    Financial income -€1,888
    Financial charges +€1,629
    Taxes -€93
    Result 2026 €111,202
    raises the resultlowers the resultnot broken down further in the accounts

    Derived cash bridge

    cash 2025 to 2026

    The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.

    From operations +€112,683
    Investment +€147,798
    Financing -€157,067
    Cash 2025 €232,594
    Net result for the year +€111,202
    Depreciation +€83,689
    Stocks and contracts -€1,010
    Receivables within one year +€4,401
    Deferred charges and accrued income -€256
    Trade debts +€8,234
    Tax, wage and social debts -€4,491
    Other debts -€88,686
    Accrued charges and deferred income -€400
    Investment in fixed assets (net) -€2,202
    Current investments +€150,000
    Debts after one year -€46,480
    Current portion of long-term debt +€413
    Contributions, distributions and other -€111,000
    Cash 2026 €336,008
    brings cash intakes cash out
    Every line side by side 49 lines
    Line Code 2025 2026 Change %
    Total assets 20/58 €1,183,729 €1,052,520 -€131,209 -11.1%
    Fixed assets 21/28 €645,193 €563,706 -€81,487 -12.6%
    Intangible fixed assets 21 €105,399 €83,209 -€22,189 -21.1%
    Tangible fixed assets 22/27 €539,794 €480,496 -€59,298 -11.0%
    Land and buildings 22 €498,832 €451,502 -€47,330 -9.5%
    Plant, machinery and equipment 23 €15,631 €12,151 -€3,481 -22.3%
    Furniture and vehicles 24 €25,331 €16,843 -€8,488 -33.5%
    Current assets 29/58 €538,536 €488,814 -€49,722 -9.2%
    Stocks and contracts in progress 3 €78,738 €79,748 +€1,010 +1.3%
    Stocks 30/36 €78,738 €79,748 +€1,010 +1.3%
    Amounts receivable within one year 40/41 €74,823 €70,422 -€4,401 -5.9%
    Trade receivables 40 €74,823 €70,422 -€4,401 -5.9%
    Current investments 50/53 €150,000 - -€150,000
    Cash at bank and in hand 54/58 €232,594 €336,008 +€103,414 +44.5%
    Deferred charges and accrued income 490/1 €2,381 €2,637 +€256 +10.7%
    Total equity and liabilities 10/49 €1,183,729 €1,052,520 -€131,209 -11.1%
    Equity 10/15 €724,196 €724,397 +€202 0.0%
    Contributions 10/11 €220,000 €220,000 = 0.0%
    Reserves 13 €339,000 €339,000 = 0.0%
    Tax-exempt reserves 132 €15,000 €15,000 = 0.0%
    Distributable reserves 133 €324,000 €324,000 = 0.0%
    Profit (loss) carried forward 14 €165,196 €165,397 +€202 +0.1%
    Amounts payable 17/49 €459,534 €328,123 -€131,410 -28.6%
    Amounts payable after more than one year 17 €85,531 €39,051 -€46,480 -54.3%
    Financial debts 170/4 €85,531 €39,051 -€46,480 -54.3%
    Amounts payable within one year 42/48 €373,602 €289,072 -€84,530 -22.6%
    Current portion of amounts payable after more than one year 42 €46,067 €46,480 +€413 +0.9%
    Trade debts 44 €98,293 €106,527 +€8,234 +8.4%
    Suppliers 440/4 €98,293 €106,527 +€8,234 +8.4%
    Taxes, remuneration and social security 45 €36,151 €31,660 -€4,491 -12.4%
    Taxes 450/3 €18,222 €13,213 -€5,009 -27.5%
    Remuneration and social security 454/9 €17,929 €18,447 +€518 +2.9%
    Other amounts payable 47/48 €193,091 €104,405 -€88,686 -45.9%
    Accrued charges and deferred income 492/3 €400 - -€400
    Non-recurring operating income 76A - €2,250 +€2,250
    Remuneration, social security and pensions 62 €84,443 €81,346 -€3,097 -3.7%
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €84,080 €83,689 -€391 -0.5%
    Other operating charges 640/8 €2,986 €3,144 +€158 +5.3%
    Non-recurring operating charges 66A - €3,570 +€3,570
    Gross operating margin 9900 €340,284 €338,652 -€1,631 -0.5%
    Operating profit (loss) 9901 €168,774 €166,903 -€1,871 -1.1%
    Financial income 75/76B €3,151 €1,263 -€1,888 -59.9%
    Recurring financial income 75 €3,151 €1,263 -€1,888 -59.9%
    Financial charges 65/66B €2,662 €1,032 -€1,629 -61.2%
    Recurring financial charges 65 €2,662 €1,032 -€1,629 -61.2%
    Profit (loss) for the period before taxes 9903 €169,264 €167,134 -€2,130 -1.3%
    Income taxes 67/77 €55,839 €55,933 +€93 +0.2%
    Profit (loss) for the period 9904 €113,425 €111,202 -€2,223 -2.0%
    Profit (loss) for the period to be appropriated 9905 €113,425 €111,202 -€2,223 -2.0%

    Value

    latest balance sheet 31-03-2026 · indication, not a valuation or advice

    Indicative value of the equity

    Indication, not a valuation or advice
    €705,654 to €859,679

    Midpoint €769,831 · 50% capitalised earnings, 50% adjusted equity

    Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

    Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

    Adjusted equity €641,188
    Capitalised earnings €770,121 to €1.1m
    Indication €705,654 to €859,679

    Adjusted equity

    balance sheet 31-03-2026
    Equity (10/15)
    €724,397
    Intangible fixed assets (21)
    -€83,209
    Revaluation of assets
    €0
    Deferred tax on the revaluation
    €0
    Other adjustment
    €0
    Adjusted equity
    €641,188

    Capitalised earnings

    net result for the year (9904)
    2026
    €111,202
    excluding non-recurring income and charges
    €112,521
    2025
    €113,425
    2024
    €101,120
    excluding non-recurring income and charges
    €97,504
    2023
    €111,146
    excluding non-recurring income and charges
    €111,341
    2022
    €93,928
    Average result, excluding non-recurring income and charges
    €107,817
    Divided by the capitalisation rate
    14% / 12% / 10%
    Capitalised earnings
    €770,121 / €898,475 / €1.1m

    Limits of the indication

    • Checked holds no market prices or comparable transactions.
    • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
    • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
    • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
    • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

    For a valuation to base a decision on, go to a company auditor or a certified accountant.

    Calculation and sources

    Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 March 2025 and 31 March 2026. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.